Correlation Between Medincell and Biosynex

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medincell and Biosynex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medincell and Biosynex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medincell SA and Biosynex, you can compare the effects of market volatilities on Medincell and Biosynex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medincell with a short position of Biosynex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medincell and Biosynex.

Diversification Opportunities for Medincell and Biosynex

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Medincell and Biosynex is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Medincell SA and Biosynex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biosynex and Medincell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medincell SA are associated (or correlated) with Biosynex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biosynex has no effect on the direction of Medincell i.e., Medincell and Biosynex go up and down completely randomly.

Pair Corralation between Medincell and Biosynex

Assuming the 90 days trading horizon Medincell SA is expected to generate 0.57 times more return on investment than Biosynex. However, Medincell SA is 1.77 times less risky than Biosynex. It trades about 0.05 of its potential returns per unit of risk. Biosynex is currently generating about -0.34 per unit of risk. If you would invest  1,568  in Medincell SA on September 28, 2024 and sell it today you would earn a total of  108.00  from holding Medincell SA or generate 6.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Medincell SA  vs.  Biosynex

 Performance 
       Timeline  
Medincell SA 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Medincell SA are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Medincell may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Biosynex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biosynex has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Medincell and Biosynex Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medincell and Biosynex

The main advantage of trading using opposite Medincell and Biosynex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medincell position performs unexpectedly, Biosynex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biosynex will offset losses from the drop in Biosynex's long position.
The idea behind Medincell SA and Biosynex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing